FDA Amends J&J Vaccine Fact Sheet to Include Rare Bleeding Risk

Published on January 11, 2022

The Food and Drug Administration on Tuesday amended the fact sheet for Johnson & Johnson’s COVID-19 vaccine to include a rare risk of immune thrombocytopenia, a bleeding disorder.”Reports of adverse events following use of the Janssen COVID-19 vaccine under emergency use…

Read Full Article (External Site)